AI-driven biopharmaceutical company InSilico Medicine Cayman TopCo (“InSilico Medicine”) officially listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, trading under the ticker 3696. It became the first AI biopharma company to successfully list under Rule 8.05 of the HKEX Main Board Listing Rules.The IPO set multiple records. Total funds raised reached HK$2.277 billion (approx. US$294 million), making it the largest biotech IPO in Hong Kong by proceeds in 2025. The Hong Kong publi ...